Moderna stock jumps 50% as Merck cancer vaccine trial succeeds
Covered by 2 sources · 2 articles
2 outlets - including Beincrypto and Cryptonomist - are covering this story. Moderna stock exploded 95% after its mRNA cancer vaccine with Merck scored the first-ever positive Phase 3 result. The post Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough appeared first on BeInCrypto .
All coverage
Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough
Moderna stock exploded 95% after its mRNA cancer vaccine with Merck scored the first-ever positive Phase 3 result. The post Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough appeared first on BeInCrypto .
Moderna stock jumps 50% as Merck cancer vaccine trial succeeds
Moderna stock (MRNA) enters a pivotal moment. The daily chart remains firmly bullish, while intraday timeframes show a brief pullback. On August 19, positive Phase 3 INTerpath-001 results from Moderna and Merck triggered headlines of a 50%…